Protalix Share Price
AMEX: PLX | Micro Cap | HealthcareProtalix Stock Performance
Protalix Share Price Today
As of 19 November 2026, Protalix BioTherapeutics, Inc.'s share price is $3.00. The stock opened at $2.92, compared to its previous close of $2.90. During today's trading session, Protalix BioTherapeutics, Inc.'s share price traded between $2.90 and $3.01, with an average price of $2.96. Over the past 52 weeks, the stock has recorded a high of $3.19 and a low of $1.65. In terms of performance, Protalix BioTherapeutics, Inc.'s share price has risen by 42.76% over the last six months and is up 67.88% on a year-on-year basis.
Protalix Share Price Chart
Protalix Quarterly Profit & Loss
All figures in USD
Protalix Annual Profit & Loss
All figures in USD
Protalix Balance Sheet
All figures in USD Million
Protalix Cash Flow
All figures in USD Million
Corporate Actions
About Protalix
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
Protalix Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.60 | $3.00 | +15.83% |
Oct 2026 | $2.73 | $2.59 | -5.82% |
Sep 2026 | $2.62 | $2.75 | +5.36% |
Aug 2026 | $2.45 | $2.61 | +9.66% |
Jul 2026 | $2.33 | $2.38 | +2.81% |
Jun 2026 | $2.10 | $2.31 | +9.98% |
May 2026 | $2.14 | $2.10 | -1.64% |
Apr 2026 | $2.21 | $2.14 | -2.28% |
Mar 2026 | $2.80 | $2.19 | -23.96% |
Feb 2026 | $2.35 | $2.88 | +24.14% |
Jan 2026 | $1.83 | $2.32 | +29.25% |
Dec 2025 | $1.77 | $1.79 | +0.28% |